Total Colonic Hirschsprung's Disease: The Hypermotility and Skin Rash Protocol

Abstract

Introduction Total colonic Hirschsprung's disease (TCHD) presents a postoperative challenge due to multiple stools and perineal rash. We propose a protocol developed by pediatric surgeons and ostomy nurses to help prevent and treat hypermotility and severe perineal rash, especially in younger children who are not toilet trained.

Materials and Methods We retrospectively reviewed our TCHD patients' charts from 2014 to 2017. All patients received a prescribed protocol for the treatment of hypermotility and perineal rash. We describe patients who underwent their pull through before and after the age of urine toilet training, and assessed the number of bowel movements, the perineal skin status, and growth.

Results We treated 25 patients. Out of 25, 9 patients received a straight ileoanal pull through before the age of 18 months. Nine of 25 patients presented for a second opinion and had redo pull through. The remaining seven presented for bowel management after having a pull through at another institution. All these were treated following the hypermotility protocol. In total, 19 of 25 patients were not toilet trained. The mean number of bowel movements in all groups was 4 (3–5). All had a resolution of perineal rash and liquid stools after 3 months. Eleven of the 25 patients presented with failure to thrive. Two older patients experienced severe proctalgia requiring replacement of the ileostomy.

Conclusion TCHD patients who underwent definitive pull through had nine high incidence of multiple stool, perineal rash, and low growth. With the implementation of bowel management care to slow the stools and a perineal skin protocol to treat the skin, we believe that these symptoms can be minimized even in patients who are not toilet trained. Since the implementation of this protocol, we have changed our practice to perform the pull through in such patients between the age of 6 and 18 months.

Keywords

total colonic Hirschsprung's disease - hypermotility - perineal rash - medical management

• References

• 1 Ikeda K, Goto S. Total colonic aganglionosis with or without small bowel involvement: an analysis of 137 patients. J Pediatr Surg 1986; 21 (04) 319-322
• 2 Bischoff A, Levitt MA, Peña A. Total colonic aganglionosis: a surgical challenge. How to avoid complications?. Pediatr Surg Int 2011; 27 (10) 1047-1052
• 3 Stenström P, Brautigam M, Borg H, Graneli C, Lilja HE, Wester T. Patient-reported Swedish nationwide outcomes of children and adolescents with total colonic aganglionosis. J Pediatr Surg 2017; 52 (08) 1302-1307
• 4 Marquez TT, Acton RD, Hess DJ, Duval S, Saltzman DA. Comprehensive review of procedures for total colonic aganglionosis. J Pediatr Surg 2009; 44 (01) 257-265
• 5 Cheung S-T, Tam Y-H, Chong H-M. , et al. An 18-year experience in total colonic aganglionosis: from staged operations to primary laparoscopic endorectal pull-through. J Pediatr Surg 2009; 44 (12) 2352-2354
• 6 Shen C, Song Z, Zheng S, Xiao X. A comparison of the effectiveness of the Soave and Martin procedures for the treatment of total colonic aganglionosis. J Pediatr Surg 2009; 44 (12) 2355-2358
• 7 Barrena S, Andres AM, Burgos L. , et al. Long-term results of the treatment of total colonic aganglionosis with two different techniques. Eur J Pediatr Surg 2008; 18 (06) 375-379
• 8 Hukkinen M, Koivusalo A, Merras-Salmio L, Rintala RJ, Pakarinen MP. Postoperative outcome and survival in relation to small intestinal involvement of total colonic aganglionosis. J Pediatr Surg 2015; 50 (11) 1859-1864
• 9 Martin LW. Surgical management of Hirschsprung's disease involving the small intestine. Arch Surg 1968; 97 (02) 183-189
• 10 Martin LW. Surgical management of total colonic aganglionosis. Ann Surg 1972; 176 (03) 343-346
• 11 Kimura K, Nishijima E, Muraji T, Tsugawa C, Matsumoto Y. A new surgical approach to extensive aganglionosis. J Pediatr Surg 1981; 16 (06) 840-843
• 12 Rintala RJ, Lindahl HG. Proctocolectomy and J-pouch ileo-anal anastomosis in children. J Pediatr Surg 2002; 37 (01) 66-70
• 13 Lal DR, Nichol PF, Harms BA, Go LL, Lund DP. Ileo-anal S-Pouch reconstruction in patients with total colonic aganglionosis after failed pull-through procedure. J Pediatr Surg 2004; 39 (07) e7-e9
• 14 Duhamel B. A new operation for the treatment of Hirschsprung's disease. Arch Dis Child 1960; 35: 38-39
• 15 Levitt MA, Dickie B, Peña A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Semin Pediatr Surg 2010; 19 (02) 146-153
• 16 Chatoorgoon K, Pena A, Lawal TA, Levitt M. The problematic Duhamel pouch in Hirschsprung's disease: manifestations and treatment. Eur J Pediatr Surg 2011; 21 (06) 366-369
• 17 Dickie BH, Webb KM, Eradi B, Levitt MA. The problematic Soave cuff in Hirschsprung disease: manifestations and treatment. J Pediatr Surg 2014; 49 (01) 77-80
• 18 Ikawa H, Masuyama H, Hirabayashi T, Endo M, Yokoyama J. More than 10 years' follow-up to total colonic aganglionosis--severe iron deficiency anemia and growth retardation. J Pediatr Surg 1997; 32 (01) 25-27
• 19 Wildhaber BE, Teitelbaum DH, Coran AG. Total colonic Hirschsprung's disease: a 28-year experience. J Pediatr Surg 2005; 40 (01) 203-206
• 20 Roorda D, Witvliet MJ, Wellens LM. , et al. Long-term outcome and quality of life in patients with total colonic aganglionosis in the Netherlands. Colorectal Dis 2018; 20 (08) 719-726
• 21 Wittmeier K, Holland C, Hobbs-Murison K. , et al. Analysis of a parent-initiated social media campaign for Hirschsprung's disease. J Med Internet Res 2014; 16 (12) e288
• 22 Bechtold ML, McClave SA, Palmer LB. , et al. The pharmacologic treatment of short bowel syndrome: new tricks and novel agents. Curr Gastroenterol Rep 2014; 16 (07) 392
• 23 Nightingale JMD, Walker ER, Farthing MJG, Lennard-Jones JE. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991; 5 (04) 405-412
• 24 O'Neil M, Teitelbaum DH, Harris MB. Total body sodium depletion and poor weight gain in children and young adults with an ileostomy: a case series. Nutr Clin Pract 2014; 29 (03) 397-401
• 25 Bower TR, Pringle KC, Soper RT. Sodium deficit causing decreased weight gain and metabolic acidosis in infants with ileostomy. J Pediatr Surg 1988; 23 (06) 567-572
• 26 Sacher P, Hirsig J, Gresser J, Spitz L. The importance of oral sodium replacement in ileostomy patients. Prog Pediatr Surg 1989; 24: 226-231
• 27 Vilanova-Sanchez A, Halleran DR, Reck-Burneo CA. , et al. A descriptive model for a multidisciplinary unit for colorectal and pelvic malformations. J Pediatr Surg 2019; 54 (03) 479-485
• 28 Marty TL, Seo T, Sullivan JJ, Matlak ME, Black RE, Johnson DG. Rectal irrigations for the prevention of postoperative enterocolitis in Hirschsprung's disease. J Pediatr Surg 1995; 30 (05) 652-654
• 29 Patrus B, Nasr A, Langer JC, Gerstle JT. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg 2011; 46 (01) 184-187
• 30 Han-Geurts IJM, Hendrix VC, de Blaauw I, Wijnen MHWA, van Heurn ELW. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr 2014; 59 (05) 604-607
• 31 Halleran DR, Lu PL, Ahmad H. , et al. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: a large institutional study and review of the literature focusing on complications. J Pediatr Surg 2019;